Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Abraxane, Adam, age, American, animal, assumed, Avastin, bacterial, began, Berk, Bio, BioScience, biotechnology, Booth, British, Bruce, Celgene, Celularity, certified, chairing, children, CHO, Claimant, classification, Clickstream, coli, College, Cornell, counsel, created, cumulative, decision, degree, disagreement, discovery, doctorate, Dual, earned, East, entity, expand, expedient, faculty, family, fellowship, franchise, Gleevec, global, GoooGreen, Greg, Handelman, Hockey, Hospital, indirect, Intellikine, Interglobal, internship, IVAX, Janex, joining, Kasower, Kinase, League, LLC, mammalian, medicine, member, Michael, monthly, MSA, mTOR, Nominating, noncurrent, nutraceutical, opening, oversaw, person, pivotal, practical, Presbyterian, prometic, relevant, Reserve, residency, School, Squibb, stipend, succeeded, supplement, SV, Theorem, toy, TriKEDual, USA, valid, Venture, Verastem, Vice, Virgin, vivo, Waste, Weill, Wendel, Western, York
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.19 Settlement Agreement
- 10.20 Form of Settlement Note
- 10.21 Steve Weldon Letter of Resignation
- 10.22 Board Service Agreement
- 10.23 Board Service Agreement
- 10.24 Consultant Agreement
- 31.1 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 32.1 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
GTBP similar filings
Filing view
External links
Exhibit 10.21
November 11, 2020
Anthony Cataldo
GT Biopharma Inc.
9350 Wilshire Blvd., Suite 203
Beverly Hills, CA 990212
Mr. Cataldo:
This letter is my notice of resignation as the Chief Financial Officer and Director of GT Biopharma, Inc. effective immediately.
Sincerely,
/s/ Steven Weldon
Steven Weldon, MBA, CPA